Frank Ornelas - Vitamin Blue Chairman
| VTMB Stock | USD 0.0001 0.00 0.00% |
Chairman
Mr. Frank D. Ornelas is President, Chief Executive Officer, Treasurer, Director of Vitamin Blue Inc. He has served as President and Chief Executive Officer of Vitamin Blue since he founded the company in 1999. Previously from 1983 to 1999, he held different positions in the financial services industry including securities analyst, options and bond trader and stockbroker with various financial firms since 1999.
| Age | 63 |
| Tenure | 25 years |
| Phone | 949-645-4592 |
| Web | https://www.vitaminblue.com |
Vitamin Blue Management Efficiency
The company has return on total asset (ROA) of (1.4042) % which means that it has lost $1.4042 on every $100 spent on assets. This is way below average. Vitamin Blue's management efficiency ratios could be used to measure how well Vitamin Blue manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Nick Caporella | National Beverage Corp | 88 | |
| James Koch | Boston Beer | 74 | |
| Jose Carbajal | Fomento Economico Mexicano | 70 | |
| Robert Gamgort | Keurig Dr Pepper | 62 | |
| Hilton Schlosberg | Monster Beverage Corp | 71 | |
Management Performance
| Return On Asset | -1.4 |
Vitamin Blue Leadership Team
Elected by the shareholders, the Vitamin Blue's board of directors comprises two types of representatives: Vitamin Blue inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vitamin. The board's role is to monitor Vitamin Blue's management team and ensure that shareholders' interests are well served. Vitamin Blue's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vitamin Blue's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Veronica Ornelas, VP and Secretary | ||
| Frank Ornelas, Founder, Chairman, CEO and President CFO, Principal Accounting Officer and Treasurer |
Vitamin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Vitamin Blue a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.4 | |||
| Operating Margin | (0.78) % | |||
| Current Valuation | 766.89 K | |||
| Shares Outstanding | 783.4 M | |||
| Price To Earning | (0.40) X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 250.03 K | |||
| Gross Profit | 55.5 K | |||
| EBITDA | (112.37 K) | |||
| Net Income | (21.08 K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Vitamin Pink Sheet
Vitamin Blue financial ratios help investors to determine whether Vitamin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vitamin with respect to the benefits of owning Vitamin Blue security.